C
CMPS
Compass Pathways Plc
5.49
-0.26-4.52%Opening15:10 04/07 EDT
OPEN/PREV CLOSE5.69/5.75
TODAY RANGE5.41-5.69
VOL926.18K
MARKET CAP707.79M
52 WEEK RANGE2.250-8.90
AVG VOL (3M)2.92M
% TURNOVER0.72%
TURNOVER--
P/E (TTM)-1.7833
% RANGE4.87%
EPS(TTM)-3.0786
P/E(FORWARD)-3.9783
P/B-9.9818
BVPS-0.5500
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP648.23M
SHARES OUTSTANDING128.92M
NEXT EARNINGS05/06-05/11
FREE FLOAT118.07M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/28 14:37
LifeSci Capital Keeps Their Buy Rating on COMPASS Pathways (CMPS)
Dow Jones·03/26 15:15
Compass Pathways Is Maintained at Buy by Canaccord Genuity
Dow Jones·03/26 15:15
Compass Pathways Price Target Cut to $18.00/Share From $20.00 by Canaccord Genuity
Benzinga·03/26 15:05
Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $18
TipRanks·03/26 15:00
Psychedelic: Compass Pathways, NRx Pharma report earnings results
TipRanks·03/26 01:48
RBC Capital Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)
TipRanks·03/25 21:35
Compass Pathways price target lowered to $18 from $20 at Canaccord
Dow Jones·03/25 17:47
Compass Pathways Is Maintained at Overweight by Morgan Stanley
Dow Jones·03/25 17:47
Compass Pathways Price Target Cut to $16.00/Share From $18.00 by Morgan Stanley
TipRanks·03/25 16:26
Oppenheimer Sticks to Their Buy Rating for COMPASS Pathways (CMPS)
Same Industry
Name/Symbol
Change%
Price